CNTN2 and mesenchymal cell neoplasm: Transgenic mice expressing Tax through HTLV-1 LTR were found to develop neurofibrosarcomas [221], mesenchymal tumors [222] or skeletal bone abnormalities [223], but not leukemias or lymphomas.